Valuation Sandu Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 05:02:14 2026-11-08 EST			5-day change	1st Jan Change
36.71 ^INR	0.00%		+2.11%	-1.92%

09-11	Sandu Pharmaceuticals Limited Approves Appointment of Neeti Madan Kapre as Non Executive Independent Director, Effective 11 July 2026	CI
09-11	Sandu Pharmaceuticals Limited Approves Re-Designation of Balram Viswanathan as Managing Director, Effective from 11 July 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	253.1	619.8	593.1	554.4	473.3	294.9
Change	-	144.92%	-4.32%	-6.51%	-14.64%	-37.7%
Enterprise Value (EV) ¹	136.7	578.1	570.1	543	451.5	230.5
Change	-	322.88%	-1.38%	-4.75%	-16.85%	-48.95%
P/E	20.7x	37.6x	32.4x	38x	30.6x	16.7x
PBR	0.76x	1.7x	1.29x	1.37x	1.13x	0.68x
PEG	-	1.8x	-2.3x	-6.01x	5.13x	1.2x
Capitalization / Revenue	0.43x	0.95x	0.91x	0.82x	0.7x	0.42x
EV / Revenue	0.23x	0.88x	0.87x	0.81x	0.67x	0.33x
EV / EBITDA	6.91x	21.5x	24.5x	25.5x	17.8x	8.34x
EV / EBIT	8.53x	24.7x	29x	31.7x	21.6x	9.92x
EV / FCF	2.36x	-540x	-50.5x	-60.4x	-254x	4.79x
FCF Yield	42.4%	-0.19%	-1.98%	-1.66%	-0.39%	20.9%
Dividend per Share ²	0.5	0.75	0.75	0.8	0.8	1
Rate of return	1.56%	1.07%	1.44%	1.39%	1.63%	3.28%
EPS ²	1.54	1.87	1.612	1.51	1.6	1.828
Distribution rate	32.5%	40.1%	46.5%	53%	50%	54.7%
Net sales ¹	587.6	655	653.5	672.8	671.9	699.3
EBITDA ¹	19.8	26.94	23.23	21.3	25.4	27.65
EBIT ¹	16.02	23.44	19.69	17.12	20.94	23.23
Net income ¹	10.92	15.89	15.2	14.61	15.52	17.66
Net Debt ¹	-116.4	-41.71	-22.96	-11.43	-21.76	-64.37
Reference price ²	31.95	70.35	52.20	57.39	48.99	30.52
Nbr of stocks (in thousands)	7,921	8,811	11,362	9,661	9,661	9,661
Announcement Date	9/6/21	9/7/22	9/6/23	9/5/24	9/6/25	8/19/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SANDU PHARMACEUTICALS LIMITED	-	-	-	-	3.77M
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,206B
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	665B
ABBVIE INC.	37.52x	8.51x	17.57x	2.38%	515B
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	381B
MERCK & CO., INC.	104.15x	5.94x	25.33x	2.32%	362B
NOVARTIS AG	23.47x	5.94x	14.26x	2.69%	307B
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	289B
AMGEN INC.	23.75x	7.3x	13.55x	2.19%	249B
GILEAD SCIENCES, INC.	-39.18x	7.27x	45.77x	1.98%	207B
Average	30.58x	7.24x	21.18x	2.04%	417.97B
Weighted average by Cap.	36.30x	8.55x	21.85x	1.73%